First-line treatment with enfortumab vedotin and pembrolizumab provides durable benefits over chemotherapy in advanced urothelial carcinoma.

A 50-year-old woman presents to the dermatology clinic with a 1-day history of an itchy, pink rash that began on her abdomen and quickly spread to her back, arms, and legs ... with erythematous, ...

Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...

The subtypes of skin manifestations found were inflammatory manifestations (most with maculopapular rash), vascular (most with livedo/purpura ... The trunk of the body was most affected by ...

Arm's stock fell after its latest quarterly report despite delivering better-than-expected numbers and impressive year-over-year growth. The stock is expensively valued right now, but Arm's ...

Commissions do not affect our editors' opinions or evaluations. ARMs are home loans whose rates can vary over the life of the loan. Unlike a fixed-rate mortgage, which carries the same interest ...

The U.K.-headquartered chip design company Arm Holdings Plc. is reportedly planning to launch its first-ever complete semiconductor after securing Facebook’s parent company Meta Platforms Inc ...

A day after a surge on the announcement of the Stargate project, some investors reacted with skepticism about Arm's role in the new artificial intelligence (AI) venture. Softbank may have to sell ...

In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information by sharing relevant background and ...

President Biden announced the arms sales at the end of his administration, and President Trump is pushing it soon after his meeting with Prime Minister Benjamin Netanyahu of Israel. By Edward Wong ...

To summarize, data from the FIREFLY-1 trial were collected from a total of 137 patients in 2 study arms. The first treatment arm evaluated OJEMDA in 77 patients aged 6 months to 25 years suffering ...